Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check6 days agoChange DetectedA new site revision label 'Revision: v3.3.4' was added, replacing the previous 'Revision: v3.3.3'. This update is related to internal versioning and does not modify study data or user-facing content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFooter now shows Revision: v3.3.3 and no longer lists HHS Vulnerability Disclosure or Revision: v3.3.2.SummaryDifference0.1%

- Check56 days agoChange DetectedRecord History now shows a new site revision entry: v3.3.2, updating from v3.2.0. This is a routine platform update; no changes to study details are apparent.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the government funding/operating status notice from the top of the page.SummaryDifference0.4%

- Check77 days agoChange DetectedNew screenshot shows additional version entries in the Record History and expanded Study Status/Contacts-Locations sections. The changes are administrative updates to the history view and do not modify core trial data such as eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0). The core impact is informing users about potential delays and where to check status.SummaryDifference9%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.